Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 691 AL 705

Effectiveness of Novel Drug Delivery System using Curcumin in Alzheimer's Disease

Aswar U, Rathod K, Mathure D.

Cent Nerv Syst Agents Med Chem. 2024;24(3):281-293. doi: 10.2174/0118715249279534240214111155.

More failure with solanezumab - this time in preclinical Alzheimer's disease

Doggrell SA.

Expert Opin Biol Ther. 2024 Mar;24(3):119-123. doi: 10.1080/14712598.2024.2325551. Epub 2024 Mar 3.

The Unveiling of Therapeutic Targets for Alzheimer's Disease: An Integrative Review

Madar P, Nagalapur P, Chaudhari S, Sharma D, Koparde A, Buchade R, Kshirsagar S, Uttekar P, Jadhav S, Chaudhari P.

Curr Top Med Chem. 2024;24(10):850-868. doi: 10.2174/0115680266282492240220101049.

Exploring Potential of Nano-formulations in the Treatment of Alzheimer's Disease through Nasal Route

Tekade A, Kadam P, Jagdale S, Surwade S, Gaikwad A, Pawar P, Shinde R.

Curr Alzheimer Res. 2024;21(10):693-709. doi: 10.2174/0115672050290462240222092303.

Lactate/Hydroxycarboxylic Acid Receptor 1 in Alzheimer's Disease: Mechanisms and Therapeutic Implications-Exercise Perspective

Meng X, Wu W, Tang Y, Peng M, Yang J, Yuan S, Hu Z, Liu W.

Mol Neurobiol. 2024 Oct;61(10):7717-7731. doi: 10.1007/s12035-024-04067-x. Epub 2024 Mar 1.

Cognitive Effect of Transcranial Direct Current Stimulation on Left Dorsolateral Prefrontal Cortex in Mild Alzheimer's Disease: A Randomized, Double-Blind, Cross-Over Small-Scale Exploratory Study

Wang CS, Chen PS, Tsai TY, Hou NT, Tang CH, Chen PL, Huang YC, Cheng KS.

J Alzheimers Dis. 2024;98(2):563-577. doi: 10.3233/JAD-240002.

Aβ-binding with alcohol dehydrogenase drives Alzheimer's disease pathogenesis: A review

Ye Z, Liu Y, Jin X, Wu Y, Zhao H, Gao T, Deng Q, Cheng J, Lin J, Tong Z.

Int J Biol Macromol. 2024 Apr;264(Pt 2):130580. doi: 10.1016/j.ijbiomac.2024.130580. Epub 2024 Mar 1.

Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis

Gao Y, Liu Y, Li Y.

Adv Clin Exp Med. 2024 Nov;33(11):1179-1187. doi: 10.17219/acem/176051.

Unraveling Amentoflavone's Therapeutic Potential in Alzheimer's Disease: A Preclinical Assessment

Singh S, Agrawal N, Goyal A.

Comb Chem High Throughput Screen. 2024;27(13):1851-1860. doi: 10.2174/0113862073301291240229102657.

Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy

Wong CYJ, Baldelli A, Hoyos CM, Tietz O, Ong HX, Traini D.

Drug Deliv Transl Res. 2024 Jul;14(7):1776-1793. doi: 10.1007/s13346-024-01558-1. Epub 2024 Mar 5.

Protein-protein interaction network analysis for the identification of novel multi-target inhibitors and target miRNAs against Alzheimer's disease

Kumar V, Roy K.

Adv Protein Chem Struct Biol. 2024;139:405-467. doi: 10.1016/bs.apcsb.2023.11.005. Epub 2024 Feb 15.

Recent advances in the total synthesis of galantamine, a natural medicine for Alzheimer's disease

Cheng B, Wang Q, An Y, Chen F.

Nat Prod Rep. 2024 Jul 17;41(7):1060-1090. doi: 10.1039/d4np00001c.

Molecular hybridization: a powerful tool for multitarget drug discovery

de Sena Murteira Pinheiro P, Franco LS, Montagnoli TL, Fraga CAM.

Expert Opin Drug Discov. 2024 Apr;19(4):451-470. doi: 10.1080/17460441.2024.2322990. Epub 2024 Mar 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias